Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.

Zhou Y, Ji Z, Yan W, Zhou Z, Li H, Xiao Y

DOI: 10.3892/or.2017.5768
Published: 2017 Aug
Container: Oncology reports
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/or.2017.5768,
  title = {Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.},
  author = {Zhou Y and Ji Z and Yan W and Zhou Z and Li H and Xiao Y},
  year = {2017},
  journal = {Oncology reports},
  doi = {10.3892/or.2017.5768},
  url = {https://doi.org/10.3892/or.2017.5768}
}

RIS

TY  - JOUR
TI  - Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
AU  - Zhou Y
AU  - Ji Z
AU  - Yan W
AU  - Zhou Z
AU  - Li H
AU  - Xiao Y
PY  - 2017
JO  - Oncology reports
DO  - 10.3892/or.2017.5768
UR  - https://doi.org/10.3892/or.2017.5768
ER  -

APA

Y, Z., Z, J., W, Y., Z, Z., H, L., & Y, X. (2017). Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.. Oncology reports. https://doi.org/10.3892/or.2017.5768

Source records

pubmed · retrieved 2026-09-24T19:39:08.159Z